Advisory Board April 12, 2024

Drug shortages in the United States reached a record high of 323, which health experts say will “likely get worse before they get better.”

Toolkit: Resources to build a modern and resilient supply chain

Drug shortages hit a record high

According to a new bulletin published by the American Society of Health-System Pharmacists (ASHP), the number of ongoing and active drug shortages in the United States is currently 323 — the highest number recorded since ASHP began tracking data in 2001. The number of drug shortages has also been over 300 for over a year now.

The drugs in short supply include both basic and life-saving products, such as oxytocin, pain and sedation treatments, chemotherapy, and more. The top five...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, HHS, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Survey / Study, Trends
Building Resilience: CDMO Strategies for Drug Supply Chain Stability
Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s
STAT+: How Trump’s tariffs may raise health care costs, from medical devices to prescription drugs
One Institution’s Evidence-Based Approach to Adopting Biosimilars
Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries

Share This Article